---
category: news
title: "First Head & Neck Cancer Patient Treated in France in a Phase I Trial With TG4050 (myvac Platform), Transgenes Innovative Individualized Immunotherapy"
excerpt: "Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that a first patient with head and neck cancer has been dosed with the Companyâ€™s innovative individualized immunotherapy,"
publishedDateTime: 2021-01-21T08:56:00Z
originalUrl: "https://www.financialbuzz.com/first-head-neck-cancer-patient-treated-in-france-in-a-phase-i-trial-with-tg4050-myvac-platform-transgenes-innovative-individualized-immunotherapy/"
webUrl: "https://www.financialbuzz.com/first-head-neck-cancer-patient-treated-in-france-in-a-phase-i-trial-with-tg4050-myvac-platform-transgenes-innovative-individualized-immunotherapy/"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Financial Buzz
  domain: financialbuzz.com

topics:
  - AI in Healthcare
  - AI

secured: "FzH4aBWHp3OWCLespir52OauKKp3dcYQQAZ45KpamjJJtIXdtZEujhW3UdozxfjFC25IJVHh7VOCfWHls1CJz/A/xY8BxdlsDYoxQseXkH/oo3CgZnnhSUCC3A9A58jSFYIpBG5M0Bx4SrCa1UcBvOpb9AFYSq2YK0jv2EU3PXz9aGUUpXuF+BkQfdrfiUeAsnw4D4Z9Fj/LOUyV9ks3X1EEMAqd447KnzPAUWbdIMTJSI5P5RZwyeD38as+MTb3kuc4XiZaPHcdG7SO4wMRWebdcueJEJE9MUoUmxAECFn/638k0/pGNItKS3t2xrEcRk3i7Sdny+RdoWso4W9LUN2xQsABFESxlmukJKILRsk=;OGqIR/kVb5qzET+xaG2QBg=="
---

